PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023
54:35
Latest Advances in Ovarian Cancer: What To Know
1:00:25
Expanding horizons in the treatment of endometrial cancer: ESGO 2023 guide clinical practice?
27:01
M1 CRPC: PARP Inhibitors, Microsatellite Instability and Precision Medicine
58:44
What’s New with PARP Inhibitors and Ovarian Cancer?
1:00:52
Report Back from SGO: What’s the Latest in Ovarian Cancer?
51:31
Insights from EHA and ISTH 2024: How can we optimize care for patients with chronic ITP?
57:11
Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel Approaches
1:37:34